Paraplegia in Pregnancy

Demir, Caner Feyzi; Yıldız, Mustafa Zahid; Özdemir, Haşan; Kapan, Oktay; Bozgeyik, Zülkif; Berilgen, Said; Aygün, Banu; Erol, Fatih Serhat

doi:10.1097/brs.0b013e31825c66ab

Cited by 10 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3) In addition to the controversy about the terminology and pathological associations, there is no consensus about the optimal treatment for symptomatic spinal AVMs, and few KTS patients have been treated for spinal AVMs (Table 1). 2,4,[6][7][8][9][10][14][15][16][17][18][19][20][21][22][23][24][25][26][27]29) Here we describe the treatment of a 29-year-old man who was diagnosed with KTS at the age of 8 years at a different institution and presented with symptomatic conus medullaris-cauda AVM treated by multisession endovascular embolization. The patient recovered from his symptoms within 3 months, and no further neurological deterioration was observed during a 2-year follow-up period.…”

Section: Introductionmentioning

confidence: 99%

Conus Medullaris-Cauda Arteriovenous Malformation and Klippel-Trenaunay Syndrome: What is the Treatment Goal?

Sgubin

Kanai

Paola

et al. 2013

Neurol. Med. Chir.(Tokyo)

View full text Add to dashboard Cite

A 29-year-old man with Klippel-Trenaunay syndrome (KTS) presented with a symptomatic conus medullaris-cauda arteriovenous malformation (AVM) manifesting as back and right limb pain, which abruptly worsened with the onset of right limb weakness and urinary retention. He was treated by multisession endovascular embolization resulting in improved neurological status. KTS is a sporadic disease with unknown etiology, but genetic susceptibility may lead to the over-expression of angiogenic factors and increased angiogenesis. KTS may be exceptionally associated with slow-flow spinal AVM, but there is no consensus about the optimal treatment for these symptomatic lesions. Embolization treatment may represent a safe option to minimize complications and possibly improve the neurological status in patients with spinal AVM associated with KTS, if one or both legs are already impaired by hypertrophy or other vascular malformations. Genetic analysis may reveal an underlying angiogenesis change, so closer follow up might be indicated in selected patients.

show abstract